0001209191-19-043147.txt : 20190724
0001209191-19-043147.hdr.sgml : 20190724
20190724195901
ACCESSION NUMBER: 0001209191-19-043147
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190724
FILED AS OF DATE: 20190724
DATE AS OF CHANGE: 20190724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aspinall Mara G.
CENTRAL INDEX KEY: 0001623049
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 19972141
MAIL ADDRESS:
STREET 1: 7381 NORTH MOON SPIRIT LANE
CITY: TUCSON
STATE: AZ
ZIP: 85718
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770701744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 820 S FRIENDSWOOD DRIVE
STREET 2: SUITE 201
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2019-07-24
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001623049
Aspinall Mara G.
C/O CASTLE BIOSCIENCES, INC.
820 S. FRIENDSWOOD DRIVE, SUITE 201
FRIENDSWOOD
TX
77546
1
0
0
0
Common Stock
23630
D
Stock option (right to buy)
1.92
2026-01-17
Common Stock
1118
D
Stock option (right to buy)
16.00
2029-07-23
Common Stock
30895
D
Series F Preferred Stock
Common Stock
14093
D
25% of the shares vested on January 18, 2017, and the remaining shares vest in 36 equal monthly installments thereafter.
25% of the shares shall vest on August 1, 2020, and the remaining shares vest in 36 equal monthly installments thereafter.
All outstanding shares of Preferred Stock will automatically convert into shares of Common Stock immediately upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration at a rate of 1 share of Common Stock for each 1.219 shares of Preferred Stock,
based on the conversion price currently in effect. The Preferred Stock has no expiration date.
/s/ Greg Acosta, Attorney-in-fact
2019-07-24
EX-24.3_865957
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all, by these presents, that the undersigned hereby constitutes and
appoints each of Derek Maetzold, Frank Stokes and Greg Acosta, signing
individually, the undersigned's true and lawful attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of Castle Biosciences, Inc.
(the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules
thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact or (c) as to any attorney-in-fact
individually, until such attorney-in-fact shall no longer be employed by the
Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 17th day of July, 2019.
/s/ Mara Aspinall